Cardiac Device Announcements Coincide with Major Meeting

Several major companies have announced FDA approval of heart devices as the Heart Rhythm Society's annual meeting begins in San Francisco. Medtronic received approval for its Vision 3D portfolio of heart and cardiac resynchronization defibrillators; Boston Scientific followed suit with two new defibrillators, which the company says are among the smallest and thinnest in the world; and St. Jude received both FDA and European approval for a small-diameter pacemaker lead.

May 14, 2008

1 Min Read
Cardiac Device Announcements Coincide with Major Meeting

While the marketing plan is hardly a coincidence, according to an analyst quoted in the Star Tribune, no one knows yet if it'll be enough to spark movement in a market that has weakened since the device recalls in 2005.Cook Medical launched its Evolution mechanical extraction sheath technology. The device is designed to aid doctors during cardiac lead extraction procedures. It is used in patients that require the percutaneous dilation of tissue surrounding leads, indwelling catheters, and foreign objects.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like